+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biotechnology Services Market - Global Forecast 2026-2032- Product Image
Biotechnology Services Market - Global Forecast 2026-2032- Product Image
Sale

Biotechnology Services Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6010910
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biotechnology Services Market is projected to reach USD 268.83 Billion in 2026. It is expected to continue growing at a CAGR of 11.99%, reaching USD 531.07 Billion by 2032.

Biotechnology Services: Executive Summary

Biotechnology services encompass specialized capabilities that support research, development, testing, manufacturing, regulatory compliance, and commercialization across biopharmaceutical, agricultural, industrial, and diagnostic applications. The field is shaped by demand for scientific expertise, flexible infrastructure, quality assurance, and integrated support across increasingly complex development pathways. Service users are placing greater emphasis on reproducibility, data integrity, regulatory readiness, and the ability to move efficiently between discovery, validation, scale-up, and production.

Integrated Workflows and Specialized Capabilities Are Reshaping Biotechnology Services

The landscape is shifting from isolated project support toward integrated, multidisciplinary workflows. Outsourced research, analytical testing, process development, clinical support, biomanufacturing, and regulatory services are increasingly coordinated to reduce handoff risk and improve continuity of technical knowledge. At the same time, advances in cell and gene therapies, biologics, precision medicine, synthetic biology, and advanced diagnostics are increasing demand for specialized capabilities, validated platforms, and flexible facilities. Service providers must therefore combine scientific depth with strong quality systems, secure data practices, supply-chain resilience, and the ability to adapt to changing regulatory expectations.

Artificial Intelligence Is Accelerating Discovery, Operations, and Quality Management

Artificial intelligence is influencing biotechnology services through experimental design, biomarker identification, image analysis, molecular modeling, process optimization, document review, and predictive quality monitoring. Its value depends on high-quality datasets, transparent validation, appropriate human oversight, and controls for bias, cybersecurity, intellectual property, and data provenance. In laboratory and manufacturing environments, AI can help prioritize work and identify deviations earlier, but it does not remove the need for qualified personnel, validated methods, robust governance, or compliance with applicable standards. Organizations that integrate AI with laboratory information systems, manufacturing records, and regulatory workflows can improve decision support while preserving accountability.

Regional Conditions Create Distinct Biotechnology Service Priorities

North America combines deep research ecosystems, advanced biomanufacturing capabilities, and strong demand for specialized outsourced services, while regulatory and reimbursement considerations continue to influence adoption. Europe emphasizes quality, data protection, cross-border coordination, and sustainable production, with the European Union providing an important framework for collaboration. Asia-Pacific is strengthened by expanding research capacity, manufacturing expertise, and growing biotechnology investment, although regulatory maturity and infrastructure vary across markets. Latin America is developing capabilities in biopharmaceutical production, agricultural biotechnology, diagnostics, and clinical research, with access to financing and technical infrastructure remaining important considerations. The Middle East is pursuing biotechnology as part of broader diversification and innovation agendas, supported by investment in research, healthcare, and advanced production. Africa presents opportunities in diagnostics, public health, agriculture, and locally relevant research, while workforce development, laboratory infrastructure, and supply continuity remain central priorities.

International Groups Influence Standards, Collaboration, and Service Demand

ASEAN economies are strengthening regional cooperation in healthcare, manufacturing, agriculture, and research, while differences in regulatory systems and infrastructure require adaptable operating models. BRICS members represent diverse scientific, industrial, and public-health priorities, creating opportunities for collaboration alongside complex cross-border requirements. The European Union supports coordinated research, shared regulatory principles, and data-governance expectations across member states. G7 economies contribute substantial scientific, healthcare, and industrial capabilities and place strong emphasis on quality, resilience, security, and responsible innovation. GCC countries are building biotechnology capacity through investment, healthcare transformation, and economic diversification, with talent and technology transfer remaining important. NATO members bring together varied biotechnology and health-security capabilities, making preparedness, biosafety, secure supply chains, and trusted data exchange especially relevant.

Country-Level Capabilities Vary by Science, Regulation, and Infrastructure

Australia combines strong biomedical research with agricultural and environmental biotechnology priorities, while Brazil has significant relevance in agriculture, bioprocessing, healthcare, and biodiversity-related research. Canada offers established life-science expertise and public research capacity, and China is expanding biotechnology research, manufacturing, and domestic innovation under a complex regulatory environment. France, Germany, Italy, Spain, and the United Kingdom contribute strong academic, healthcare, industrial, and regulatory capabilities, with differing specialization across research, clinical development, diagnostics, and production. India combines a large scientific workforce with expanding pharmaceutical, clinical, and analytical service capabilities. Japan emphasizes advanced research, quality, and precision manufacturing, while South Korea is strengthening biologics, diagnostics, and technology-intensive production. Mexico is developing capabilities linked to healthcare manufacturing, diagnostics, and nearshore supply chains. Russia maintains scientific and industrial capabilities but operates within distinct trade, regulatory, and collaboration conditions. The United States remains a major center for biotechnology research, clinical development, advanced manufacturing, and specialized service demand, supported by extensive academic, healthcare, and investment ecosystems.

Leaders Should Build Resilient, Compliant, and AI-Ready Service Models

Industry leaders should first map critical workflows and determine which activities require internal control, strategic partnerships, or external specialization. They should invest in validated digital infrastructure, interoperable laboratory and manufacturing systems, cybersecurity, and traceable data governance before scaling AI applications. Portfolio resilience can be improved through qualified alternative suppliers, regionalized capacity, documented technology-transfer procedures, and scenario-based continuity planning. Organizations should also strengthen workforce development in bioinformatics, process engineering, quality assurance, regulatory affairs, and data science. Finally, partnership decisions should assess scientific fit, validation evidence, inspection readiness, intellectual-property protection, sustainability performance, and the ability to support programs across development stages and geographies.

Research Methodology for the Biotechnology Services Assessment

This executive summary uses a structured qualitative assessment of biotechnology services across research, development, testing, manufacturing, regulatory, and commercialization activities. The analysis organizes evidence by technology transition, operational requirement, geography, international group, and country, with attention to scientific capability, infrastructure, regulation, workforce, data governance, and supply-chain conditions. Insights are derived from established industry, policy, scientific, and institutional evidence rather than unsupported numerical assumptions. Because the available reference identifies the market category but does not provide a source dataset with validated numerical indicators, this summary intentionally excludes market estimates, market shares, forecasts, and company-level claims.

Biotechnology Services Will Reward Integration, Trust, and Technical Adaptability

Biotechnology services are becoming more interconnected, specialized, and data-driven. Success will depend on combining scientific expertise with dependable quality systems, regulatory fluency, secure digital operations, and resilient delivery networks. Regional and country conditions will continue to shape where capabilities are developed and how services are accessed, while AI will increase the importance of validated data and accountable decision-making. Leaders that integrate disciplines, develop adaptable talent, and maintain trusted partnerships will be better positioned to support innovation without compromising safety, compliance, or operational continuity.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Biotechnology Services Market, by Service Type
7.1. Introduction
7.2. Bioinformatics Services
7.2.1. Data Analysis
7.2.2. Software Solutions
7.3. Bioprocessing
7.3.1. Fermentation Services
7.3.2. Purification Services
7.4. Cell Therapy Services
7.4.1. Allogeneic Cell Therapy
7.4.2. Autologous Cell Therapy
7.5. Custom Cell Line Development
7.5.1. Mammalian Cell Line
7.5.2. Microbial Cell Line
7.6. Drug Discovery
7.6.1. Biologics Discovery
7.6.2. Small Molecule Discovery
7.7. Genomic Services
7.7.1. PCR Services
7.7.2. Sequencing Services
8. Biotechnology Services Market, by Technology
8.1. Introduction
8.2. Analytical Techniques
8.2.1. Chromatography
8.2.2. Mass Spectrometry
8.3. Cell Culture Technologies
8.4. Genomic Technologies
8.4.1. Next Generation Sequencing
8.4.2. PCR Technology
8.5. Imaging Technologies
8.5.1. Flow Cytometry
8.5.2. Microscopy
9. Biotechnology Services Market, by Application
9.1. Introduction
9.2. Diagnostic
9.2.1. Biomarker Discovery
9.2.2. Companion Diagnostics
9.3. Drug Discovery
9.3.1. Lead Optimization
9.3.2. Target Identification
9.4. Research
9.4.1. Basic Research
9.4.2. Translational Research
9.5. Therapeutic Development
9.5.1. Clinical Trials
9.5.2. Preclinical Testing
10. Biotechnology Services Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.2.1. Government Labs
10.2.2. University Labs
10.3. Biotech Companies
10.4. Contract Research Organizations
10.4.1. Clinical Research
10.4.2. Preclinical Research
10.5. Pharmaceutical Companies
11. Biotechnology Services Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Biotechnology Services Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Biotechnology Services Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Agilent Technologies, Inc.
15.2. Catalent Inc.
15.3. Charles River Laboratories International, Inc.
15.4. Crown Bioscience, Inc.
15.5. Danaher Corporation
15.6. Eurofins Scientific SE
15.7. Fortrea Holdings Inc.
15.8. GE HealthCare Technologies Inc.
15.9. GenScript Biotech Corporation
15.10. ICON PLC
15.11. IQVIA Holdings Inc.
15.12. KBI Biopharma Inc.
15.13. Laboratory Corporation of America Holdings
15.14. Lonza Group AG
15.15. Medpace Holdings Inc.
15.16. Novotech Health Holdings Ltd.
15.17. Parexel International Corporation
15.18. PerkinElmer, Inc.
15.19. Recipharm AB
15.20. Samsung Biologics Co. Ltd.
15.21. Sartorius AG
15.22. SGS SA
15.23. Syngene International Limited
15.24. Thermo Fisher Scientific Inc.
15.25. WuXi AppTec Co., Ltd.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Biotechnology Services Market, Years Considered for the Study
FIGURE 2. Global Biotechnology Services Market, Research Design
FIGURE 3. Global Biotechnology Services Market, Research Framework
FIGURE 4. Global Biotechnology Services Market, Data Triangulation
FIGURE 5. Global Biotechnology Services Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Biotechnology Services Market Size, by Service Type, 2025 vs 2032 (%)
FIGURE 7. Global Biotechnology Services Market Size, by Service Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Biotechnology Services Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Biotechnology Services Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Biotechnology Services Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Biotechnology Services Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Biotechnology Services Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Biotechnology Services Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Biotechnology Services Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Biotechnology Services Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Biotechnology Services Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Biotechnology Services Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Biotechnology Services Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Biotechnology Services Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Biotechnology Services Market Segmentation & Coverage
TABLE 2. Global Biotechnology Services Market Size, 2017-2032 (USD Million)
TABLE 3. Global Biotechnology Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 4. Global Bioinformatics Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Bioinformatics Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Bioinformatics Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Data Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Data Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Data Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Software Solutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Software Solutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Software Solutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Bioprocessing Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Bioprocessing Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Bioprocessing Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Fermentation Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Fermentation Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Fermentation Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Purification Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Purification Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Purification Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Cell Therapy Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Cell Therapy Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Cell Therapy Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Allogeneic Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Allogeneic Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Allogeneic Cell Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Autologous Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Autologous Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Autologous Cell Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Custom Cell Line Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Custom Cell Line Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Custom Cell Line Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Mammalian Cell Line Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Mammalian Cell Line Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Mammalian Cell Line Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Microbial Cell Line Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Microbial Cell Line Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Microbial Cell Line Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Biologics Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Biologics Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Biologics Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Small Molecule Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Small Molecule Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Small Molecule Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Genomic Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Genomic Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Genomic Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global PCR Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global PCR Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global PCR Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Sequencing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Sequencing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Sequencing Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Biotechnology Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 59. Global Analytical Techniques Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Analytical Techniques Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Analytical Techniques Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Mass Spectrometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Mass Spectrometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Mass Spectrometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Cell Culture Technologies Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Cell Culture Technologies Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Cell Culture Technologies Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Genomic Technologies Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Genomic Technologies Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Genomic Technologies Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Next Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Next Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Next Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global PCR Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global PCR Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global PCR Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Imaging Technologies Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Imaging Technologies Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Imaging Technologies Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Flow Cytometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Flow Cytometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Flow Cytometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Microscopy Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Microscopy Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Microscopy Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Biotechnology Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 90. Global Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Diagnostic Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Biomarker Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Biomarker Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Biomarker Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Companion Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Companion Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Companion Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Lead Optimization Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Lead Optimization Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Lead Optimization Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Target Identification Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Target Identification Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Target Identification Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Basic Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Basic Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Basic Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global Translational Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Global Translational Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. Global Translational Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 117. Global Therapeutic Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Global Therapeutic Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. Global Therapeutic Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. Global Clinical Trials Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global Clinical Trials Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global Clinical Trials Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global Preclinical Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Preclinical Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Preclinical Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Biotechnology Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Government Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Government Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Government Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global University Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global University Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global University Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Biotech Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Biotech Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Biotech Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Clinical Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Clinical Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Clinical Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Preclinical Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Preclinical Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Preclinical Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. Global Biotechnology Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Asia-Pacific Biotechnology Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Asia-Pacific Biotechnology Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 154. Asia-Pacific Biotechnology Services Market Size, by Bioinformatics Services, 2017-2032 (USD Million)
TABLE 155. Asia-Pacific Biotechnology Services Market Size, by Bioprocessing, 2017-2032 (USD Million)
TABLE 156. Asia-Pacific Biotechnology Services Market Size, by Cell Therapy Services, 2017-2032 (USD Million)
TABLE 157. Asia-Pacific Biotechnology Services Market Size, by Custom Cell Line Development, 2017-2032 (USD Million)
TABLE 158. Asia-Pacific Biotechnology Services Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 159. Asia-Pacific Biotechnology Services Market Size, by Genomic Services, 2017-2032 (USD Million)
TABLE 160. Asia-Pacific Biotechnology Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 161. Asia-Pacific Biotechnology Services Market Size, by Analytical Techniques, 2017-2032 (USD Million)
TABLE 162. Asia-Pacific Biotechnology Services Market Size, by Genomic Technologies, 2017-2032 (USD Million)
TABLE 163. Asia-Pacific Biotechnology Services Market Size, by Imaging Technologies, 2017-2032 (USD Million)
TABLE 164. Asia-Pacific Biotechnology Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 165. Asia-Pacific Biotechnology Services Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 166. Asia-Pacific Biotechnology Services Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 167. Asia-Pacific Biotechnology Services Market Size, by Research, 2017-2032 (USD Million)
TABLE 168. Asia-Pacific Biotechnology Services Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 169. Asia-Pacific Biotechnology Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. Asia-Pacific Biotechnology Services Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 171. Asia-Pacific Biotechnology Services Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 172. North America Biotechnology Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 173. North America Biotechnology Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 174. North America Biotechnology Services Market Size, by Bioinformatics Services, 2017-2032 (USD Million)
TABLE 175. North America Biotechnology Services Market Size, by Bioprocessing, 2017-2032 (USD Million)
TABLE 176. North America Biotechnology Services Market Size, by Cell Therapy Services, 2017-2032 (USD Million)
TABLE 177. North America Biotechnology Services Market Size, by Custom Cell Line Development, 2017-2032 (USD Million)
TABLE 178. North America Biotechnology Services Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 179. North America Biotechnology Services Market Size, by Genomic Services, 2017-2032 (USD Million)
TABLE 180. North America Biotechnology Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 181. North America Biotechnology Services Market Size, by Analytical Techniques, 2017-2032 (USD Million)
TABLE 182. North America Biotechnology Services Market Size, by Genomic Technologies, 2017-2032 (USD Million)
TABLE 183. North America Biotechnology Services Market Size, by Imaging Technologies, 2017-2032 (USD Million)
TABLE 184. North America Biotechnology Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. North America Biotechnology Services Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 186. North America Biotechnology Services Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 187. North America Biotechnology Services Market Size, by Research, 2017-2032 (USD Million)
TABLE 188. North America Biotechnology Services Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 189. North America Biotechnology Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. North America Biotechnology Services Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 191. North America Biotechnology Services Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 192. Latin America Biotechnology Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 193. Latin America Biotechnology Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 194. Latin America Biotechnology Services Market Size, by Bioinformatics Services, 2017-2032 (USD Million)
TABLE 195. Latin America Biotechnology Services Market Size, by Bioprocessing, 2017-2032 (USD Million)
TABLE 196. Latin America Biotechnology Services Market Size, by Cell Therapy Services, 2017-2032 (USD Million)
TABLE 197. Latin America Biotechnology Services Market Size, by Custom Cell Line Development, 2017-2032 (USD Million)
TABLE 198. Latin America Biotechnology Services Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 199. Latin America Biotechnology Services Market Size, by Genomic Services, 2017-2032 (USD Million)
TABLE 200. Latin America Biotechnology Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 201. Latin America Biotechnology Services Market Size, by Analytical Techniques, 2017-2032 (USD Million)
TABLE 202. Latin America Biotechnology Services Market Size, by Genomic Technologies, 2017-2032 (USD Million)
TABLE 203. Latin America Biotechnology Services Market Size, by Imaging Technologies, 2017-2032 (USD Million)
TABLE 204. Latin America Biotechnology Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. Latin America Biotechnology Services Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 206. Latin America Biotechnology Services Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 207. Latin America Biotechnology Services Market Size, by Research, 2017-2032 (USD Million)
TABLE 208. Latin America Biotechnology Services Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 209. Latin America Biotechnology Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. Latin America Biotechnology Services Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 211. Latin America Biotechnology Services Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 212. Europe Biotechnology Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 213. Europe Biotechnology Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 214. Europe Biotechnology Services Market Size, by Bioinformatics Services, 2017-2032 (USD Million)
TABLE 215. Europe Biotechnology Services Market Size, by Bioprocessing, 2017-2032 (USD Million)
TABLE 216. Europe Biotechnology Services Market Size, by Cell Therapy Services, 2017-2032 (USD Million)
TABLE 217. Europe Biotechnology Services Market Size, by Custom Cell Line Development, 2017-2032 (USD Million)
TABLE 218. Europe Biotechnology Services Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 219. Europe Biotechnology Services Market Size, by Genomic Services, 2017-2032 (USD Million)
TABLE 220. Europe Biotechnology Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 221. Europe Biotechnology Services Market Size, by Analytical Techniques, 2017-2032 (USD Million)
TABLE 222. Europe Biotechnology Services Market Size, by Genomic Technologies, 2017-2032 (USD Million)
TABLE 223. Europe Biotechnology Services Market Size, by Imaging Technologies, 2017-2032 (USD Million)
TABLE 224. Europe Biotechnology Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 225. Europe Biotechnology Services Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 226. Europe Biotechnology Services Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 227. Europe Biotechnology Services Market Size, by Research, 2017-2032 (USD Million)
TABLE 228. Europe Biotechnology Services Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 229. Europe Biotechnology Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. Europe Biotechnology Services Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 231. Europe Biotechnology Services Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 232. Middle East Biotechnology Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 233. Middle East Biotechnology Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 234. Middle East Biotechnology Services Market Size, by Bioinformatics Services, 2017-2032 (USD Million)
TABLE 235. Middle East Biotechnology Services Market Size, by Bioprocessing, 2017-2032 (USD Million)
TABLE 236. Middle East Biotechnology Services Market Size, by Cell Therapy Services, 2017-2032 (USD Million)
TABLE 237. Middle East Biotechnology Services Market Size, by Custom Cell Line Development, 2017-2032 (USD Million)
TABLE 238. Middle East Biotechnology Services Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 239. Middle East Biotechnology Services Market Size, by Genomic Services, 2017-2032 (USD Million)
TABLE 240. Middle East Biotechnology Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 241. Middle East Biotechnology Services Market Size, by Analytical Techniques, 2017-2032 (USD Million)
TABLE 242. Middle East Biotechnology Services Market Size, by Genomic Technologies, 2017-2032 (USD Million)
TABLE 243. Middle East Biotechnology Services Market Size, by Imaging Technologies, 2017-2032 (USD Million)
TABLE 244. Middle East Biotechnology Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 245. Middle East Biotechnology Services Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 246. Middle East Biotechnology Services Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 247. Middle East Biotechnology Services Market Size, by Research, 2017-2032 (USD Million)
TABLE 248. Middle East Biotechnology Services Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 249. Middle East Biotechnology Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. Middle East Biotechnology Services Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 251. Middle East Biotechnology Services Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 252. Africa Biotechnology Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 253. Africa Biotechnology Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 254. Africa Biotechnology Services Market Size, by Bioinformatics Services, 2017-2032 (USD Million)
TABLE 255. Africa Biotechnology Services Market Size, by Bioprocessing, 2017-2032 (USD Million)
TABLE 256. Africa Biotechnology Services Market Size, by Cell Therapy Services, 2017-2032 (USD Million)
TABLE 257. Africa Biotechnology Services Market Size, by Custom Cell Line Development, 2017-2032 (USD Million)
TABLE 258. Africa Biotechnology Services Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 259. Africa Biotechnology Services Market Size, by Genomic Services, 2017-2032 (USD Million)
TABLE 260. Africa Biotechnology Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 261. Africa Biotechnology Services Market Size, by Analytical Techniques, 2017-2032 (USD Million)
TABLE 262. Africa Biotechnology Services Market Size, by Genomic Technologies, 2017-2032 (USD Million)
TABLE 263. Africa Biotechnology Services Market Size, by Imaging Technologies, 2017-2032 (USD Million)
TABLE 264. Africa Biotechnology Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 265. Africa Biotechnology Services Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 266. Africa Biotechnology Services Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 267. Africa Biotechnology Services Market Size, by Research, 2017-2032 (USD Million)
TABLE 268. Africa Biotechnology Services Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 269. Africa Biotechnology Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 270. Africa Biotechnology Services Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 271. Africa Biotechnology Services Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 272. Global Biotechnology Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 273. ASEAN Biotechnology Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 274. ASEAN Biotechnology Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 275. ASEAN Biotechnology Services Market Size, by Bioinformatics Services, 2017-2032 (USD Million)
TABLE 276. ASEAN Biotechnology Services Market Size, by Bioprocessing, 2017-2032 (USD Million)
TABLE 277. ASEAN Biotechnology Services Market Size, by Cell Therapy Services, 2017-2032 (USD Million)
TABLE 278. ASEAN Biotechnology Services Market Size, by Custom Cell Line Development, 2017-2032 (USD Million)
TABLE 279. ASEAN Biotechnology Services Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 280. ASEAN Biotechnology Services Market Size, by Genomic Services, 2017-2032 (USD Million)
TABLE 281. ASEAN Biotechnology Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 282. ASEAN Biotechnology Services Market Size, by Analytical Techniques, 2017-2032 (USD Million)
TABLE 283. ASEAN Biotechnology Services Market Size, by Genomic Technologies, 2017-2032 (USD Million)
TABLE 284. ASEAN Biotechnology Services Market Size, by Imaging Technologies, 2017-2032 (USD Million)
TABLE 285. ASEAN Biotechnology Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 286. ASEAN Biotechnology Services Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 287. ASEAN Biotechnology Services Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 288. ASEAN Biotechnology Services Market Size, by Research, 2017-2032 (USD Million)
TABLE 289. ASEAN Biotechnology Services Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 290. ASEAN Biotechnology Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 291. ASEAN Biotechnology Services Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 292. ASEAN Biotechnology Services Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 293. GCC Biotechnology Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 294. GCC Biotechnology Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 295. GCC Biotechnology Services Market Size, by Bioinformatics Services, 2017-2032 (USD Million)
TABLE 296. GCC Biotechnology Services Market Size, by Bioprocessing, 2017-2032 (USD Million)
TABLE 297. GCC Biotechnology Services Market Size, by Cell Therapy Services, 2017-2032 (USD Million)
TABLE 298. GCC Biotechnology Services Market Size, by Custom Cell Line Development, 2017-2032 (USD Million)
TABLE 299. GCC Biotechnology Services Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 300. GCC Biotechnology Services Market Size, by Genomic Services, 2017-2032 (USD Million)
TABLE 301. GCC Biotechnology Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 302. GCC Biotechnology Services Market Size, by Analytical Techniques, 2017-2032 (USD Million)
TABLE 303. GCC Biotechnology Services Market Size, by Genomic Technologies, 2017-2032 (USD Million)
TABLE 304. GCC Biotechnology Services Market Size, by Imaging Technologies, 2017-2032 (USD Million)
TABLE 305. GCC Biotechnology Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 306. GCC Biotechnology Services Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 307. GCC Biotechnology Services Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 308. GCC Biotechnology Services Market Size, by Research, 2017-2032 (USD Million)
TABLE 309. GCC Biotechnology Services Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 310. GCC Biotechnology Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 311. GCC Biotechnology Services Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 312. GCC Biotechnology Services Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 313. European Union Biotechnology Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 314. European Union Biotechnology Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 315. European Union Biotechnology Services Market Size, by Bioinformatics Services, 2017-2032 (USD Million)
TABLE 316. European Union Biotechnology Services Market Size, by Bioprocessing, 2017-2032 (USD Million)
TABLE 317. European Union Biotechnology Services Market Size, by Cell Therapy Services, 2017-2032 (USD Million)
TABLE 318. European Union Biotechnology Services Market Size, by Custom Cell Line Development, 2017-2032 (USD Million)
TABLE 319. European Union Biotechnology Services Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 320. European Union Biotechnology Services Market Size, by Genomic Services, 2017-2032 (USD Million)
TABLE 321. European Union Biotechnology Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 322. European Union Biotechnology Services Market Size, by Analytical Techniques, 2017-2032 (USD Million)
TABLE 323. European Union Biotechnology Services Market Size, by Genomic Technologies, 2017-2032 (USD Million)
TABLE 324. European Union Biotechnology Services Market Size, by Imaging Technologies, 2017-2032 (USD Million)
TABLE 325. European Union Biotechnology Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 326. European Union Biotechnology Services Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 327. European Union Biotechnology Services Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 328. European Union Biotechnology Services Market Size, by Research, 2017-2032 (USD Million)
TABLE 329. European Union Biotechnology Services Market Size, by Therapeutic Development, 2017-2032 (USD Million)
TABLE 330. European Union Biotechnology Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 331. European Union Biotechnology Services Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 332. European Union Biotechnology Services Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 333. BRICS Biotechnology Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 334. BRICS Biotechnology Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 335. BRICS Biotechnology Services Market Size, by Bioinformatics Services, 2017-2032 (USD Million)
TABLE 336. BRICS Biotechnology Services Market Size, by Bioprocessing, 2017-2032 (USD Million)
TABLE 337. BRICS Biotechnology Services Market Size, by Cell Therapy Services, 2017-2032 (USD Million)
TABLE 338. BRICS Biotechnology Services Market Size, by Custom Cell Line Development, 2017-2032 (USD Million)
TABLE 339. BRICS Biotechnology Services Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 340. BRICS Biotechnology Services Market Size, by Genomic Services, 2017-2032 (USD Million)
TABLE 341. BRICS Biotechnology Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 342. BRICS Biotechnology Services Market Size, by Analytical Techniques, 2017-2032 (USD Million)
TABLE 343. BRICS Biotechnology Services Market Size, by Genomic Technologies, 2017-2032 (USD Million)
TABLE 344. BRICS Biotechnology Services Market Size, by Imaging Technologies, 2017-2032 (USD Million)
TABLE 345. BRICS Biotechnology Services Market Size, by Application, 2017

Companies Mentioned

  • Agilent Technologies, Inc.
  • Catalent Inc.
  • Charles River Laboratories International, Inc.
  • Crown Bioscience, Inc.
  • Danaher Corporation
  • Eurofins Scientific SE
  • Fortrea Holdings Inc.
  • GE HealthCare Technologies Inc.
  • GenScript Biotech Corporation
  • ICON PLC
  • IQVIA Holdings Inc.
  • KBI Biopharma Inc.
  • Laboratory Corporation of America Holdings
  • Lonza Group AG
  • Medpace Holdings Inc.
  • Novotech Health Holdings Ltd.
  • Parexel International Corporation
  • PerkinElmer, Inc.
  • Recipharm AB
  • Samsung Biologics Co. Ltd.
  • Sartorius AG
  • SGS SA
  • Syngene International Limited
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.

Related Topics

Related Reports

Biotechnology Market Report by Product Type, Technology, Application, and Region 2026-2034 - Product Image

Biotechnology Market Report by Product Type, Technology, Application, and Region 2026-2034

  • Report
  • 138 Pages
  • Global
From
Biotechnology Market in the US 2025-2029 - Product Image

Biotechnology Market in the US 2025-2029

  • Report
  • 170 Pages
  • United States
From
North America Biotechnology Market Report by Product Type, Technology, Application, Countries and Company Analysis 2025-2033 - Product Image

North America Biotechnology Market Report by Product Type, Technology, Application, Countries and Company Analysis 2025-2033

  • Report
  • 200 Pages
  • North America
From
Biotechnology for the Non-Biotechnologist (November 30, 2026 December 4, 2026) - Product Image

Biotechnology for the Non-Biotechnologist (November 30, 2026 December 4, 2026)

  • Training
  • 5 Days
  • Global
Biotechnology Reagents & Kits Market - Global Forecast 2026-2032 - Product Image

Biotechnology Reagents & Kits Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.